- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MERUS LABS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 18,200 | -2,41 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
21.11.2025 / 12:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| EYEPOINT | 11,290 | 0,00 % | EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug | ||
| AMARIN | 12,500 | 0,00 % | Amarin Corporation plc: Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline | ||
| SELLAS LIFE SCIENCES | 4,260 | +0,71 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update | - Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 Events - - First Patient Dosed in Phase 2 Trial of... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 19,265 | -2,28 % | CATALYST PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| MADRIGAL PHARMACEUTICALS | 388,80 | +0,49 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | ||
| ANI PHARMACEUTICALS | 64,00 | -1,54 % | Barclays bestätigt "Overweight"-Rating für Aktie von ANI Pharmaceuticals | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| DOGECOIN CASH | - | - | Dogecoin Cash, Inc. Announces Completion of Unit Distribution Processing and DTC Participant Allocation | MESQUITE, NV, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Mesquite, Nevada - January 29, 2026 - Dogecoin Cash, Inc. (OTC: DOGP) (the "Company") today announced that Colonial Stock Transfer Company, Inc. ("Colonial")... ► Artikel lesen | |
| BLUM HOLDINGS | - | - | Blum Holdings: Blüm Holdings Announces $3.05 Million Debt Conversion | ||
| BMP PHARMA TRADING | 5,100 | 0,00 % | PTA-News: B.M.P. Pharma Trading AG: Konzern weiterhin auf Erfolgskurs - Die Gesellschaft steigert das operative Halbjahresergebnis im Geschäftsjahr 2025 | DJ PTA-News: B.M.P. Pharma Trading AG: Konzern weiterhin auf Erfolgskurs - Die Gesellschaft steigert das operative Halbjahresergebnis im Geschäftsjahr 2025
Unternehmensmitteilung für den Kapitalmarkt... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,189 | +1,67 % | Theriva Biologics, Inc.: Theriva Biologics Reports Full-Year 2025 Operational Highlights and Financial Results | - Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma -
- Licensed SYN-020 to Rasayana Therapeutics for development in multiple indications; up to $38... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 7,550 | -4,67 % | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | ||
| ALLERGY THERAPEUTICS | 0,113 | +3,67 % | Allergy Therapeutics - PDMR Dealings & Shareholding Update | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - 8-K, Current Report |
Das Unternehmen MERUS LABS INTERNATIONAL INC kann der Branche Pharma zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MERUS LABS INTERNATIONAL INC finden Sie auf Wallstreet Online.